Related Experiment Video
Updated: Jun 29, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Multiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A
Joseph S Durgin1, Carli P Whittington2, Mallory Joseph1
1Department of Dermatology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Dermatofibrosarcoma protuberans (DFSP) can present as multiple tumors. Chromosomal microarray analysis revealed distinct genomic alterations in two separate DFSP cases, indicating multiple primary malignant events rather than metastasis.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer known for local invasion and recurrence.
- Distinguishing multiple primary DFSP from metastatic disease presents a diagnostic challenge.
- The characteristic t(17;22) translocation and COL1A1::PDGFB fusion are key diagnostic markers, though assay sensitivity can vary.
Observation:
- A patient developed two distinct DFSP tumors over a 7-year period.
- Standard diagnostic assays for the COL1A1::PDGFB fusion showed variable sensitivity.
- Chromosomal microarray analysis was employed to investigate the genomic landscape of both tumors.
Findings:
- The two DFSP tumors exhibited distinct genomic alterations upon chromosomal microarray analysis.
- These distinct alterations support the hypothesis of multiple independent primary malignant events.
- This finding contrasts with the expectation of a shared clonal origin in metastatic or multifocal disease.
Implications:
- Chromosomal microarray analysis can be a valuable tool in diagnosing multifocal DFSP.
- This case highlights the importance of comprehensive genomic evaluation in complex DFSP presentations.
- Understanding the distinct genomic profiles of multiple DFSP tumors aids in accurate diagnosis and patient management.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023